Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi

J. Nyirenda (Freiburg, Germany), D. Wagner (Freiburg, Germany), B. Ngwira (Blantyre, Malawi), B. Lange (Braunschweig, Germany)

Source: Virtual Congress 2020 – Tuberculosis and comorbidities

Session: Tuberculosis and comorbidities
Session type: E-poster session
Number: 480

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Nyirenda (Freiburg, Germany), D. Wagner (Freiburg, Germany), B. Ngwira (Blantyre, Malawi), B. Lange (Braunschweig, Germany). Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi. 480

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Treatment outcomes of new TB cases among children in Russia Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Management of tuberculosis (TB) at a district general hospital: An audit of practice Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Tuberculosis infection control measures assessment in diabetic healthcare facilities Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Impact and management of TB childhood outbreaks in EU/EEA Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Patient and health system delays for tuberculosis patients diagnosed in medical colleges of Puducherry in India Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Increased incidence of TB disease within the health-care workers in an intermediate TB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015